HESI TECHNICAL COMMITTEE ON IMAGING FOR TRANSLATIONAL SAFETY ASSESSMENT
The mission of the HESI Technical Committee on Translational Imaging in Safety Assessment is to build a multi-sector and multi-specialty team of scientists to identify and pursue opportunities to impactfully integrate imaging approaches into current safety assessment paradigms for drugs and/or hazard assessment approaches for chemicals.
| Committee Factsheet
Committee Presentations and Data Resources
2014-2015 Participating Organizations
Astellas Pharma Inc.
AstraZeneca Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Duke University Center for In Vivo Microscopy
Hoffman-La Roche Inc.
National Institutes of Health (US)
Seoul National University
Takeda Pharmaceutical Company Limited
University of North Carolina – Chapel Hill
US Environmental Protection Agency
US Food and Drug Administration
Recent Committee Publications
Johnson GA, Calabrese E, Little PB, Hedlund L, Qi Y, Badea A: Quantitative mapping of trimethyltin injury in the rat brain using magnetic resonance histology. Neurotoxicology 2014, 42C:12-23. More details
G. Allan Johnson, PhD
Teyent Getaneh, email@example.com